Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA01030852 delta2-THA 2E,6Z,9Z,12Z,15Z,18Z,21Z-tetracosaheptaenoic acid FA 24:7 C24H34O2 354.255881
LMFA08020105 N-docosahexaenoyl GABA N-(4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoyl)-gamma-aminobutyric acid NA 26:7;O2 C26H39NO3 413.292994
LMFA08020105 N-docosahexaenoyl GABA N-(4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoyl)-gamma-aminobutyric acid NA 26:7;O2 C26H39NO3 413.292994
LMFA07010029 WE 25:0/16:1(9Z) Pentacosanyl 9Z-hexadecenoate WE 41:1 C41H80O2 604.615831
LMFA07010029 WE 25:0/16:1(9Z) Pentacosanyl 9Z-hexadecenoate WE 41:1 C41H80O2 604.615831
LMFA02030054 16-epi-16-E1c-PhytoP 8-((1R,2S,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)octanoic acid FA 18:3;O3 C18H30O5 326.209326
LMFA08020107 N-palmitoyl threonine N-hexadecanoyl-threonine NAThr 16L0 C20H39NO4 357.287909
LMFA08020107 N-palmitoyl threonine N-hexadecanoyl-threonine NAThr 16L0 C20H39NO4 357.287909
LMFA01030868 21:2(5Z,16Z) 5Z,16Z-heneicosadienoic acid FA 21:2 C21H38O2 322.287181
LMFA08020121 N-linoleoyl valine N-(9Z,12Z-octadecadienoyl)-valine NAVal 18:2 C23H41NO3 379.308644
LMFA08020121 N-linoleoyl valine N-(9Z,12Z-octadecadienoyl)-valine NAVal 18:2 C23H41NO3 379.308644
LMFA08020121 N-linoleoyl valine N-(9Z,12Z-octadecadienoyl)-valine NAVal 18:2 C23H41NO3 379.308644
LMFA08020122 N-stearoyl valine N-octadecanoyl-valine NAVal 18:0 C23H45NO3 383.339944
LMFA08020122 N-stearoyl valine N-octadecanoyl-valine NAVal 18:0 C23H45NO3 383.339944
LMFA08020129 N-docosahexaenoyl glutamine N-(4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoyl)-glutamine NAGln 22:6 C27H40N2O4 456.298808
LMFA08020129 N-docosahexaenoyl glutamine N-(4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoyl)-glutamine NAGln 22:6 C27H40N2O4 456.298808
LMFA08020129 N-docosahexaenoyl glutamine N-(4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoyl)-glutamine NAGln 22:6 C27H40N2O4 456.298808
LMFA03110107 ent-PGD2 9R,15R-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8S,12S] FA 20:4;O3 C20H32O5 352.224976
LMFA08020135 N-stearoyl histidine N-octadecanoyl-histidine NAHis 18:0 C24H43N3O3 421.330442
LMFA01030872 30:3(5Z,9Z,23Z) 5Z,9Z,23Z-triacontatrienoic acid FA 30:3 C30H54O2 446.412381
LMFA01020361 27:2(5Z,9Z)(25Me) 25-methyl-5Z,9Z-heptacosadienoic acid FA 28:2 C28H52O2 420.396731
LMFA01020361 27:2(5Z,9Z)(25Me) 25-methyl-5Z,9Z-heptacosadienoic acid FA 28:2 C28H52O2 420.396731
LMFA01020362 27:2(5Z,9Z)(26Me) 26-methyl-5Z,9Z-heptacosadienoic acid FA 28:2 C28H52O2 420.396731
LMFA01020362 27:2(5Z,9Z)(26Me) 26-methyl-5Z,9Z-heptacosadienoic acid FA 28:2 C28H52O2 420.396731
LMFA01020366 29:2(5Z,9Z)(26Me) 26-methyl-5Z,9Z-octacosadienoic acid FA 30:2 C30H56O2 448.428031
LMFA01020366 29:2(5Z,9Z)(26Me) 26-methyl-5Z,9Z-octacosadienoic acid FA 30:2 C30H56O2 448.428031
LMFA01030909 21:1(7Z) 7Z-heneicosenoic acid FA 21:1 C21H40O2 324.302831
LMFA02030023 ent-16-F1c-PhytoP 8-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)octanoic acid FA 18:2;O3 C18H32O5 328.224976
LMFA08020234 N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide C29H55N3O3 493.424342
LMFA08020234 N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide C29H55N3O3 493.424342
LMFA08020234 N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide C29H55N3O3 493.424342
LMFA07070061 Docosa-4,7,10,13,16-pentaenoyl carnitine 3-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyloxy]-4-(trimethylazaniumyl)butanoate CAR 22:5 C29H47NO4 473.350510
LMFA07070061 Docosa-4,7,10,13,16-pentaenoyl carnitine 3-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyloxy]-4-(trimethylazaniumyl)butanoate CAR 22:5 C29H47NO4 473.350510
LMFA04030004 Resolvin D6 4S,17S-dihydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230061
LMFA04030004 Resolvin D6 4S,17S-dihydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230061
LMFA04030004 Resolvin D6 4S,17S-dihydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230061
LMFA12000022 3-Hydroxypentan-2-one 3-Hydroxypentan-2-one C5H10O2 102.068080
LMFA04030005 AT-Resolvin D1 7S,8R,17R-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O3 C22H32O5 376.224976
LMFA04030005 AT-Resolvin D1 7S,8R,17R-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O3 C22H32O5 376.224976
LMFA04030005 AT-Resolvin D1 7S,8R,17R-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O3 C22H32O5 376.224976
LMFA04030009 8-oxo-Resolvin D1 8-oxo-7S,17S-dihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:7;O3 C22H30O5 374.209326
LMFA04030009 8-oxo-Resolvin D1 8-oxo-7S,17S-dihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:7;O3 C22H30O5 374.209326
LMFA04030009 8-oxo-Resolvin D1 8-oxo-7S,17S-dihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:7;O3 C22H30O5 374.209326
LMFA04030009 8-oxo-Resolvin D1 8-oxo-7S,17S-dihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:7;O3 C22H30O5 374.209326
LMFA13010061 1-hydroxy-2-(beta-D-glucosyloxy)-9,10-anthraquinone 1-hydroxy-2-(beta-D-glucopyranosyloxy)-9,10-anthraquinone C20H18O9 402.095085
LMFA03110229 8-epi-5-D2c-IsoP (S,E)-5-hydroxy-7-((1S,2S,5S)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA08020259 N-(14Z-tricosenoyl) taurine N-(14Z-tricosenoyl) taurine NAT 23:1 C25H49NO4S 459.338230
LMFA02000422 6(Z),9(Z),12(Z)-18-HOTrE 18-hydroxyoctadeca-6Z,9Z,12Z-trienoic acid FA 18:3;O C18H30O3 294.219496
LMFA02000422 6(Z),9(Z),12(Z)-18-HOTrE 18-hydroxyoctadeca-6Z,9Z,12Z-trienoic acid FA 18:3;O C18H30O3 294.219496
LMFA02000422 6(Z),9(Z),12(Z)-18-HOTrE 18-hydroxyoctadeca-6Z,9Z,12Z-trienoic acid FA 18:3;O C18H30O3 294.219496